These emerging medications , including Semaglutide , belong to a group of drugs called GLP-1 receptor agonists . Primarily intended for treating diabetes mellitus , they function by encouraging the organism to produce sufficient insulin and curbing increased sugar levels. Beyond diabetes, their capacity to support weight loss has resulted to substa